Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis.
Chromatin Landscape Defined by Repressive Histone Methylation during Oligodendrocyte Differentiation.
Preferred features of oral treatments and predictors of non-adherence: two web-based choice experiments in multiple sclerosis patients.
Epstein-Barr virus infection: A smoking gun for multiple sclerosis?
Ginkgo biloba does not improve cognitive function in MS: A randomized placebo-controlled trial.
Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination.
A salty taste to autoimmunity.
Pilot study of minocycline in relapsing-remitting multiple sclerosis.
Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease.
Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta.
Early versus delayed treatment with laquinimod demonstrated significant reduction in risk of disability progression – Results of three-year ALLEGRO study in relapsing-remitting multiple sclerosis
[Assessment of the risk of the transition of a monofocal clinically isolated syndrome to clinically definite multiple sclerosis.]
Genetic control of nerve conduction velocity may influence multiple sclerosis phenotype.
Endothelial microparticles interact with and support the proliferation of T cells.
Neuroprotective effects of chrysin: From chemistry to medicine.
Influence of fingolimod on basic lymphocyte subsets frequencies in the peripheral blood of multiple sclerosis patients - preliminary study.
Contribution of MicroRNAs to autoimmune diseases.
Clostridia as agents of zoonotic disease.
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial.
Multidisciplinary management of multiple sclerosis symptoms.
Simulating neurodegeneration through longitudinal population analysis of structural and diffusion weighted MRI data.
[Levels of Beclin 1 and LC3 in peripheral blood mononuclear cells of patients with multiple sclerosis and neuromyelitis optica and its significance].
A concise synthesis of Fingolimod: an orally available drug for treating multiple sclerosis.
[A retrospective study of patients with early onset of multiple sclerosis in Omskaya Oblast.]
Reduced Retinal Nerve Fiber Layer Thickness and Macular Volume in Pediatric Multiple Sclerosis.
Pages
« first
‹ previous
…
319
320
321
322
323
324
325
326
327
…
next ›
last »